Efg Asset Management (Americas) Corp. Fibrogen Inc Transaction History

Efg Asset Management (Americas) Corp.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$18.57 - $35.68 $132,645 - $254,862	-7,143 Closed	0 $0
Q1 2021 Apr 09, 2021	BUY	$31.0 - $55.72 $53,134 - $95,504	1,714 Added 31.57%	7,143 $248,000
Q4 2020 Feb 05, 2021	SELL	$37.09 - $48.97 $9,346 - $12,340	-252 Reduced 4.44%	5,429 $201,000
Q3 2020 Nov 06, 2020	BUY	$40.47 - $45.5 $229,910 - $258,485	5,681 New	5,681 $234,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.